Literature DB >> 10884410

Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction of p27Xic1.

C Swanson1, J Ross, P K Jackson.   

Abstract

The action of cyclin-dependent kinases (CDKs) is regulated by phosphorylation, cyclin levels, the abundance of CDK inhibitors, and, as recently has been shown for cyclin B/cdc2, their localization. It is unclear how localization regulates the action of cyclin E/Cdk2 and its inhibitors. Here, we show that the closest known Xenopus laevis homolog of mammalian Cdk2 inhibitors p27(Kip1) and p21(CIP1), Xic1, is concentrated, ubiquitinated, and destroyed in the nucleus. Furthermore, Xic1 destruction requires nuclear import, but not nuclear export, and requires the formation of a transport-competent nuclear envelope, but not interactions between the lamina and chromatin. We show that (i) cyclin E/Cdk2 and Xic1 are transported into the nucleus as a complex and that Xic1 destruction requires the activity of cyclin E, (ii) that phosphorylation of Xic1 by cyclin E/Cdk2 bypasses the requirement for nuclear formation, and (iii) that the phosphorylation of Xic1 by cyclin E/Cdk2 is concentration dependent and likely realized through second-order interactions between stable cyclin E/Cdk2/Xic1 ternary complexes. Based on these results we propose a model wherein nuclear accumulation of the cyclin E/Cdk2/Xic1 complex triggers a concentration-dependent switch that promotes the phosphorylation of Xic1 and, consequently, its ubiquitination and destruction, thus allowing subsequent activation of cyclin E/Cdk2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884410      PMCID: PMC16624          DOI: 10.1073/pnas.97.14.7796

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.

Authors:  A Montagnoli; F Fiore; E Eytan; A C Carrano; G F Draetta; A Hershko; M Pagano
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

2.  Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes.

Authors:  F Fang; J W Newport
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

3.  Cyclin E-CDK2 is a regulator of p27Kip1.

Authors:  R J Sheaff; M Groudine; M Gordon; J M Roberts; B E Clurman
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

Review 4.  Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

Authors:  A Alessandrini; D S Chiaur; M Pagano
Journal:  Leukemia       Date:  1997-03       Impact factor: 11.528

5.  Cell cycle control by Xenopus p28Kix1, a developmentally regulated inhibitor of cyclin-dependent kinases.

Authors:  W Shou; W G Dunphy
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

6.  SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities.

Authors:  R Verma; R M Feldman; R J Deshaies
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

7.  Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.

Authors:  J Vlach; S Hennecke; K Alevizopoulos; D Conti; B Amati
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

8.  Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins.

Authors:  N Mathias; S L Johnson; M Winey; A E Adams; L Goetsch; J R Pringle; B Byers; M G Goebl
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

9.  Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.

Authors:  J Y Su; R E Rempel; E Erikson; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  A role for Cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle.

Authors:  X H Hua; H Yan; J Newport
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

View more
  8 in total

1.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence.

Authors:  Yu-Liang Kuo; Chou-Zen Giam
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

3.  Xic1 degradation in Xenopus egg extracts is coupled to initiation of DNA replication.

Authors:  Zhongsheng You; Kevin Harvey; Lindsay Kong; John Newport
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

4.  Upregulation of CRM1 relates to neuronal apoptosis after traumatic brain injury in adult rats.

Authors:  Aihong Li; Feihui Zou; Hongran Fu; Gang Cui; Yaohua Yan; Qiyun Wu; Xingxing Gu
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

5.  CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis.

Authors:  Michael K Connor; Rouslan Kotchetkov; Sandrine Cariou; Ansgar Resch; Rafaella Lupetti; Richard G Beniston; Frauke Melchior; Ludger Hengst; Joyce M Slingerland
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

6.  Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication.

Authors:  L Furstenthal; B K Kaiser; C Swanson; P K Jackson
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

Review 7.  The origin of CDK regulation.

Authors:  A Li; J J Blow
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

8.  HTLV-1 Tax mutants that do not induce G1 arrest are disabled in activating the anaphase promoting complex.

Authors:  Randall Merling; Chunhua Chen; Sohee Hong; Ling Zhang; Meihong Liu; Yu-Liang Kuo; Chou-Zen Giam
Journal:  Retrovirology       Date:  2007-05-29       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.